Helen Tayton-Martin

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Helen Tayton-Martin and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Helen

Helen Tayton-Martin

Chief Business Officer

Adaptimmune

Experienced entrepreneur and technology development executive in cell therapy and oncology with experience in company foundation and set up in the UK and US, financing, taking a UK biotech company public on NASDAQ and subsequently building out and fi

Talks About
#celltherapy #oncology #busniessdevelopment

Preferred Locations
#Europe

Speaking Engagements

TCR-Based Therapies For Solid Tumors Summit

Paid

Welcome to the 3rd TCR-based Therapies for Solid Tumors Summit Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors Do you want to gain unrivalled industry knowledge to build a first-class TCR-based therapy with high efficacy and targeting power in solid tumors? The industry-leading TCR-based Therapies for Solid Tumors S

27-29 June 2022

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Helen Tayton-Martin

Chief Business Officer

Speaking Engagements

TCR-Based Therapies For Solid Tumors Summit